Position in DERM
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$47,955
-$29,093 QoQ
Shares Held
10,225
-4.7% QoQ
Ownership
0.037%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
6 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in DERM Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Cetera Investment Advisers holds $48,125,230 across 32 Drug Manufacturers - Specialty & Generic names. DERM ranks #30 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
80,566 | $9,523,706 | |
| 2 | VTRS |
Viatris Inc
|
385,999 | $5,214,846 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
8,648 | $5,128,091 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
|
224,015 | $4,148,757 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
121,502 | $2,907,542 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
20,245 | $2,667,076 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
|
87,216 | $2,626,945 | |
| 8 | HLN |
Haleon plc
|
247,741 | $2,479,887 |
All Filings in DERM
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $47,955 | 10,225 | Shares | Sole | 2026-05-13 | |
| 2025-06-30 | $77,048 | 10,731 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $89,379 | 15,149 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $54,110 | 13,839 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $64,189 | 11,361 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $104,977 | 18,613 | Shares | Sole | 2024-08-22 | |
| No filing history on record for this holder in this stock. | ||||||